Cargando…

Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction

Ventricular hypertrabeculation/noncompaction is a morphologic and functional anomaly of myocardium characterized by prominent trabeculae accompanied by deep recessus. Dilated cardiomyopathy with left ventricular failure is observed in these patients, while the cause or pathophysiologic nature of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Erer, Hatice Betül, Güvenç, Tolga Sinan, Kemik, Ahu Sarbay, Yılmaz, Hale Yaka, Kul, Şeref, Altay, Servet, Sayar, Nurten, Kaya, Yüksel, Eren, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585198/
https://www.ncbi.nlm.nih.gov/pubmed/23469039
http://dx.doi.org/10.1371/journal.pone.0057648
_version_ 1782261118099521536
author Erer, Hatice Betül
Güvenç, Tolga Sinan
Kemik, Ahu Sarbay
Yılmaz, Hale Yaka
Kul, Şeref
Altay, Servet
Sayar, Nurten
Kaya, Yüksel
Eren, Mehmet
author_facet Erer, Hatice Betül
Güvenç, Tolga Sinan
Kemik, Ahu Sarbay
Yılmaz, Hale Yaka
Kul, Şeref
Altay, Servet
Sayar, Nurten
Kaya, Yüksel
Eren, Mehmet
author_sort Erer, Hatice Betül
collection PubMed
description Ventricular hypertrabeculation/noncompaction is a morphologic and functional anomaly of myocardium characterized by prominent trabeculae accompanied by deep recessus. Dilated cardiomyopathy with left ventricular failure is observed in these patients, while the cause or pathophysiologic nature of this complication is not known. Anti-troponin antibodies are formed against circulating cardiac troponins after an acute coronary event or conditions associated with chronic myocyte necrosis, such as dilated cardiomyopathy. In present study, we aimed to investigate cardiac troponins and anti troponin autoantibodies in ventricular noncompaction/hypertrabeculation patients with/without reduced ejection fraction. A total of 50 patients with ventricular noncompaction and 23 healthy volunteers were included in this study. Noncompaction/hypertrabeculation was diagnosed with two-dimensional echocardiography using appropriate criteria. Depending on ejection fraction, patients were grouped into noncompaction with preserved EF (LVEF >50%, n = 24) and noncompaction with reduced EF (LVEF <35%, n = 26) groups. Troponin I, troponin T, anti-troponin I IgM and anti-troponin T IgM were measured with sandwich immunoassay method using a commercially available kit. Patients with noncompaction had significantly higher troponin I (28.98±9.21 ng/ml in NCNE group and 28.11±10.42 ng/ml in NCLE group), troponin T (22.17±6.97 pg/ml in NCNE group and 22.78±7.76 pg/ml in NCLE group) and antitroponin I IgM (1.92±0.43 µg/ml in NCNE group and 1.79±0.36 µg/ml in NCLE group) levels compared to control group, while antitroponin T IgM and IgG were only elevated in patients with noncompaction and reduced EF (15.81±6.52 µg/ml for IgM and 16.46±6.25 µg/ml for IgG). Elevated cardiac troponins and anti-troponin I autoantibodies were observed in patients with noncompaction preceding the decline in systolic function and could indicate ongoing myocardial damage in these patients.
format Online
Article
Text
id pubmed-3585198
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35851982013-03-06 Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction Erer, Hatice Betül Güvenç, Tolga Sinan Kemik, Ahu Sarbay Yılmaz, Hale Yaka Kul, Şeref Altay, Servet Sayar, Nurten Kaya, Yüksel Eren, Mehmet PLoS One Research Article Ventricular hypertrabeculation/noncompaction is a morphologic and functional anomaly of myocardium characterized by prominent trabeculae accompanied by deep recessus. Dilated cardiomyopathy with left ventricular failure is observed in these patients, while the cause or pathophysiologic nature of this complication is not known. Anti-troponin antibodies are formed against circulating cardiac troponins after an acute coronary event or conditions associated with chronic myocyte necrosis, such as dilated cardiomyopathy. In present study, we aimed to investigate cardiac troponins and anti troponin autoantibodies in ventricular noncompaction/hypertrabeculation patients with/without reduced ejection fraction. A total of 50 patients with ventricular noncompaction and 23 healthy volunteers were included in this study. Noncompaction/hypertrabeculation was diagnosed with two-dimensional echocardiography using appropriate criteria. Depending on ejection fraction, patients were grouped into noncompaction with preserved EF (LVEF >50%, n = 24) and noncompaction with reduced EF (LVEF <35%, n = 26) groups. Troponin I, troponin T, anti-troponin I IgM and anti-troponin T IgM were measured with sandwich immunoassay method using a commercially available kit. Patients with noncompaction had significantly higher troponin I (28.98±9.21 ng/ml in NCNE group and 28.11±10.42 ng/ml in NCLE group), troponin T (22.17±6.97 pg/ml in NCNE group and 22.78±7.76 pg/ml in NCLE group) and antitroponin I IgM (1.92±0.43 µg/ml in NCNE group and 1.79±0.36 µg/ml in NCLE group) levels compared to control group, while antitroponin T IgM and IgG were only elevated in patients with noncompaction and reduced EF (15.81±6.52 µg/ml for IgM and 16.46±6.25 µg/ml for IgG). Elevated cardiac troponins and anti-troponin I autoantibodies were observed in patients with noncompaction preceding the decline in systolic function and could indicate ongoing myocardial damage in these patients. Public Library of Science 2013-02-28 /pmc/articles/PMC3585198/ /pubmed/23469039 http://dx.doi.org/10.1371/journal.pone.0057648 Text en © 2013 Erer et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Erer, Hatice Betül
Güvenç, Tolga Sinan
Kemik, Ahu Sarbay
Yılmaz, Hale Yaka
Kul, Şeref
Altay, Servet
Sayar, Nurten
Kaya, Yüksel
Eren, Mehmet
Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction
title Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction
title_full Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction
title_fullStr Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction
title_full_unstemmed Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction
title_short Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction
title_sort troponin and anti-troponin autoantibody levels in patients with ventricular noncompaction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585198/
https://www.ncbi.nlm.nih.gov/pubmed/23469039
http://dx.doi.org/10.1371/journal.pone.0057648
work_keys_str_mv AT ererhaticebetul troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction
AT guvenctolgasinan troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction
AT kemikahusarbay troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction
AT yılmazhaleyaka troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction
AT kulseref troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction
AT altayservet troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction
AT sayarnurten troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction
AT kayayuksel troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction
AT erenmehmet troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction